FDA 483 - Sunstar Guangzhou Ltd. - June 28, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sunstar Guangzhou Ltd., an OTC (b)(4) manufacturer in Guangzhou, China, was cited for multiple significant deficiencies across its quality, laboratory, and production systems. Key issues include inadequate written procedures for quality reviews, GMP training, and quality control unit responsibilities, as well as failures in drug product testing, laboratory controls, and record-keeping. These observations indicate a systemic lack of adherence to current good manufacturing practices.
ID · 23238513-32be-49f9-a411-20ec2b7eab06